Scorpius Holdings Amends Filing to Detail Financial Aftermath of Asset Foreclosure

summarizeSummary

Scorpius Holdings, Inc. filed an amended 8-K to provide updated pro forma financial statements, detailing the severe financial impact of the December 2025 foreclosure of substantially all its non-cash assets, which resulted in a significant reduction in assets and a substantial remaining debt burden.

check_boxKey Events

• Updated Pro Forma Financials Filed

  The company filed an amended 8-K to replace previously reported pro forma financial statements (for six months ended June 30, 2025) with updated statements for the nine months ended September 30, 2025, providing a more current view of the financial impact of the asset disposition.

• Foreclosure of Substantially All Assets Confirmed

  On December 10, 2025, substantially all non-cash assets related to the company's CDMO and research and development activities were foreclosed upon by a collateral agent due to outstanding secured notes.

• Significant Debt Reduction, Substantial Remaining Debt

  Net proceeds of $15.2 million from the foreclosure sale were applied to partially settle $30.2 million in secured debt, leaving approximately $14.9 million in aggregate remaining debt obligations.

• Operational Discontinuation

  The foreclosure led to the termination of all CDMO employees and the discontinuation of the company's CDMO and R&D activities, which were its primary operations.

auto_awesomeAnalysis

This amended 8-K provides critical updated financial clarity following the previously disclosed foreclosure of substantially all of Scorpius Holdings' non-cash assets in December 2025. The replacement of six-month pro forma financials with nine-month figures offers a more current and comprehensive picture of the company's post-foreclosure financial state. The details confirm the devastating impact, with $15.2 million in foreclosure proceeds only partially settling $30.2 million in secured debt, leaving a significant $14.9 million in remaining obligations. Coupled with the termination of all CDMO employees and the cessation of core R&D activities, the company has effectively lost its operational base. This filing underscores the severe financial distress previously indicated by the company's last 10-Q, which reported cash sufficient only through February 2026, and highlights the company's transformation into a significantly smaller entity with minimal operating assets and substantial liabilities. Investors should view this as a confirmation of the company's severely impaired financial and operational viability.